Stay updated on SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.

Latest updates to the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page revision updated from v3.6.3 to v3.6.4, representing a minor version update to the page rather than a substantive content change.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page's revision marker was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version.SummaryDifference0.1%

- Check38 days agoChange DetectedThe revision indicator on the page updates to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check52 days agoChange DetectedA recruitment-status update was added stating that the study is no longer recruiting participants. This clarifies that enrollment has completed and informs readers about current availability.SummaryDifference0.4%

- Check60 days agoChange DetectedThe page's revision label changed from v3.5.4 to v3.5.5, indicating a new revision of the study record.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page footer now shows Revision: v3.5.4, replacing v3.5.3, indicating a new build of the page rendering. No changes to study content are reflected in this update.SummaryDifference0.1%

Stay in the know with updates to SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SIIT + Pembrolizumab in Follicular Lymphoma Clinical Trial page.